LXRX
USDLexicon Pharmaceuticals Inc. Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$1.330
Kõrge
$1.390
Madal
$1.325
Maht
2.72M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
487.0M
Tööstusharu
Biotehnoloogia
Riik
United States
Kauplemisstatistika
Keskmine maht
2.36M
Börs
NCM
Valuuta
USD
52 nädala vahemik
Seotud uudised
Data Demonstrating Unique Benefits of Sotagliflozin in Diverse Patient Populations will be Presented at the Hypertrophic Cardiomyopathy Society and American Heart Association's Sessions 2025 in New Orleans
THE WOODLANDS, Texas, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) today announced that data from three studies of sotagliflozin will be presented during upcoming medical meetings. Two
Lexicon Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 6, 2025
THE WOODLANDS, Texas, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) today announced the Company will release its third quarter 2025 financial results on Thursday, November 6, 2025, prior
Seotud aktsiad
TAK
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of)
SLND
Southland Holdings Inc.
TDG
Transdigm Group Incorporated
FIX
Comfort Systems USA Inc.
ATNM
Actinium Pharmaceuticals Inc. (Delaware)
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.